Table 2.
AAB levels and AAB/IgG-ratios. Differences between groups analyzed using Mann–Whitney test.
| Whole Cohort (n = 116, Median with IQR) |
w/Infection- Triggered Onset (n = 86, Median with IQR) |
w/o Infection- Triggered Onset (n = 30, Median with IQR) |
Inf. vs. Non-Inf. |
|
|---|---|---|---|---|
| alpha1-AdR-AAB | 8.71 U/l (7.24–11.65) | 8.66 U/l (7.30–11.86) | 8.83 U/l (6.85–10.02) | p: 0.400 |
| alpha2-AdR-AAB | 7.36 U/l (6.06–9.11) | 7.37 U/l (6.05–9.65) | 7.34 U/l (6.07–8.97) | p: 0.709 |
| beta1-AdR-AAB | 10.30 U/l (7.86–15.20) | 9.88 U/l (7.61–16.20) | 10.67 U/l (8.48–13.44) | p: 0.902 |
| beta2-AdR-AAB | 6.74 U/l (4.76–11.26) | 6.74 U/l (4.75–11.55) | 6.59 U/l (4.67–10.37) | p: 0.622 |
| beta3-AdR-AAB | 8.93 U/l (6.10–13.31) | 9.45 U/l (6.29–13.68) | 8.70 U/l (5.72–13.20) | p: 0.824 |
| M3-AChR-AAB | 4.74 U/l (3.41–6.10) | 4.77 U/l (3.44–7.01) | 4.45 U/l (3.37–5.62) | p: 0.293 |
| M4-AChR-AAB | 6.50 U/l (5.16–8.33) | 6.50 U/l (5.20–9.11) | 6.59 U/l (5.08–7.98) | p: 0.660 |
| AT1-R-AAB | 11.28 U/l (8.52–16.38) | 11.62 U/l (8.50–17.05) | 10.49 U/l (8.68–16.13) | p: 0.474 |
| ETA-R-AAB | 9.03 U/l (7.65–12.45) | 8.98 U/l (7.60–12.79) | 9.77 U/l (7.87–11.46) | p: 0.774 |
| ETB-R-AAB | 13.05 U/l (10.00–19.67) | 13.05 U/l (10.03–19.87) | 13.06 U/l (9.71–17.48) | p: 0.750 |
| PAR1-AAB | 4.52 U/l (3.14–5.96) | 4.76 U/l (3.26–6.31) | 3.49 U/l (3.07–4.91) | p: 0.102 |
| PAR2-AAB | 12.80 U/l (9.33–21.48) | 12.12 U/l (8.46–22.08) | 14.63 U/l (10.68–18.50) | p: 0.535 |
| alpha1-AdR-AAB/IgG | 0.90 U/g (0.78–1.20) | 0.90 U/g (0.78–1.21) | 0.90 U/g (0.77–1.13) | p: 0.626 |
| alpha2-AdR-AAB/IgG | 0.75 U/g (0.64–0.98) | 0.74 U/g (0.63–0.99) | 0.78 U/g (0.65–0.98) | p: 0.969 |
| beta1-AR-AAB/IgG | 1.06 U/g (0.82–1.54) | 1.02 U/g (0.80–1.47) | 1.14 U/g (0.86–1.57) | p: 0.595 |
| beta2-AdR-AAB/IgG | 0.71 U/g (0.49–1.12) | 0.70 U/g (0.49–1.11) | 0.78 U/g (0.44–1.15) | p: 0.897 |
| beta3-AdR-AAB/IgG | 0.88 U/g (0.66–1.31) | 0.88 U/g (0.66–1.28) | 0.89 U/g (0.67–1.49) | p: 0.989 |
| M3-AChR-AAB/IgG | 0.48 U/g (0.37–0.64) | 0.48 U/g (0.37–0.66) | 0.46 U/g (0.33–0.62) | p: 0.479 |
| M4-AChR-AAB/IgG | 0.69 U/g (0.51–0.87) | 0.69 U/g (0.51–0.88) | 0.68 U/g (0.52–0.88) | p: 0.984 |
| AT1-R-AAB/IgG | 1.16 U/g (0.92–1.73) | 1.19 U/g (0.93–1.77) | 1.14 U/g (0.85–1.47) | p: 0.414 |
| ETA-R-AAB/IgG | 0.95 U/g (0.77–1.29) | 0.93 U/g (0.76–1.34) | 1.03 U/g (0.81–1.18) | p: 0.812 |
| ETB-R-AAB/IgG | 1.29 U/g (1.02–1.93) | 1.31 U/g (1.02–2.00) | 1.29 U/g (1.00–1.82) | p: 0.707 |
| PAR1-AAB/IgG | 0.45 U/g (0.35–0.59) | 0.45 U/g (0.36–0.66) | 0.36 U/g (0.31–0.52) | p: 0.067 |
| PAR2-AAB/IgG | 1.37 U/g (0.96–1.99) | 1.36 U/g (0.92–1.98) | 1.55 U/g (1.15–2.16) | p: 0.398 |
| total IgG | 9.73 g/l (8.39–11.10) | 9.79 g/l (8.41–11.09) | 9.63 g/l (8.36–11.51) | p: 0.969 |